LundgrenMRidefeltPSvenssonMK, et al.NT-proBNP and its correlation to left ventricular ejection fraction and heart failure – the DEMONSTRATE database. Ann Clin Biochem2025; 17: 45632251403397, Published online November. https://doi.org/10.1177/00045632251403397
2.
CheitlinMAlpertJArmstrongW, et al.ACC/AHA guidelines for the clinical application of echocardiography: executive summary. J Am Coll Cardiol1997; 29(4): 862–879. https://doi.org/10.1016/s0735-1097(96)90000-5
3.
SalahKStienenSPintoYM, et al.Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction. Heart2019; 105(15): 1182–1189. https://doi.org/10.1136/heartjnl-2018-314173
4.
O'HanlonRO'SheaPLedwidgeM, et al.The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients. J Card Fail2007; 13(1): 50–55. https://doi.org/10.1016/j.cardfail.2006.09.003
5.
LundgrenMRidefeltPKarlssonM, et al.Interlaboratory variation for NT-proBNP among Swedish laboratories in an external quality program 2011–2021. Clin Chem Lab Med2023; 61(9): 1643–1651. https://doi.org/10.1515/cclm-2023-0051
6.
JanuzziJLVan KimmenadeRLainchburyJ, et al.NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients. Eur Heart J2006; 27(3): 330–337. https://doi.org/10.1093/eurheartj/ehi631
